AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
HYBRIDIZATION PROPERTIES OF NUCLEIC-ACID ANALOGS CONTAINING BETA-AMINOALANINE MODIFIED WITH NUCLEOBASES
Authors: FUJII M YOSHIDA K HIDAKA J OHTSU T
Citation: M. Fujii et al., HYBRIDIZATION PROPERTIES OF NUCLEIC-ACID ANALOGS CONTAINING BETA-AMINOALANINE MODIFIED WITH NUCLEOBASES, Chemical communications, (6), 1998, pp. 717-718
STEREOREGULAR AND BERNOULLIAN COPOLYMERIZATION OF STYRENE AND ETHYLENE BY BRIDGED METALLOCENE CATALYSTS
Authors: ARAI T OHTSU T SUZUKI S
Citation: T. Arai et al., STEREOREGULAR AND BERNOULLIAN COPOLYMERIZATION OF STYRENE AND ETHYLENE BY BRIDGED METALLOCENE CATALYSTS, Macromolecular rapid communications, 19(6), 1998, pp. 327-331
FEASIBILITY AND PHARMACOKINETIC STUDY OF A CHIMERIC ANTI-CD20 MONOCLONAL-ANTIBODY (IDEC-C2B8, RITUXIMAB) IN RELAPSED B-CELL LYMPHOMA
Authors: TOBINAI K KOBAYASHI Y NARABAYASHI M OGURA M KAGAMI Y MORISHIMA Y OHTSU T IGARASHI T SASAKI Y KINOSHITA T MURATE T
Citation: K. Tobinai et al., FEASIBILITY AND PHARMACOKINETIC STUDY OF A CHIMERIC ANTI-CD20 MONOCLONAL-ANTIBODY (IDEC-C2B8, RITUXIMAB) IN RELAPSED B-CELL LYMPHOMA, Annals of oncology, 9(5), 1998, pp. 527-534
A PHASE-I TRIAL OF TOP-53 BY HYBRID DOSE-ESCALATION STRATEGY BASED ONPGDE AND CRM
Authors: SASAKI Y OHASHI Y MINAMI H OHTSU T FUJII M IGARASHI T WATANABE Y ONOZAWA Y KODAMA K ITO K ISHIZUKA N BANDO T TSUDA M YAMAGUCHI Y SUZUKI T
Citation: Y. Sasaki et al., A PHASE-I TRIAL OF TOP-53 BY HYBRID DOSE-ESCALATION STRATEGY BASED ONPGDE AND CRM, Annals of oncology, 9, 1998, pp. 242-242
THE EFFECT OF INTRAVENOUS (IV) SDZ PSC833 (PSC) ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DOXORUBICIN (DOX) IN A PHASE-I TRIAL
Authors: OHTSU T TANIGAWARA Y FUJII H MINAMI H IGARASHI T ITOH K ONOZAWA Y WATANABE Y KODAMA K MORIKAWA H SASAKI Y
Citation: T. Ohtsu et al., THE EFFECT OF INTRAVENOUS (IV) SDZ PSC833 (PSC) ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DOXORUBICIN (DOX) IN A PHASE-I TRIAL, Annals of oncology, 9, 1998, pp. 552-552
UNEXPECTED HEPATOTOXICITIES IN PATIENTS WITH NON-HODGKINS-LYMPHOMA TREATED WITH IRINOTECAN (CPT-11) AND ETOPOSIDE
Authors: OHTSU T SASAKI Y IGARASHI T MURAYAMA T KOBAYASHI Y TOBINAI K
Citation: T. Ohtsu et al., UNEXPECTED HEPATOTOXICITIES IN PATIENTS WITH NON-HODGKINS-LYMPHOMA TREATED WITH IRINOTECAN (CPT-11) AND ETOPOSIDE, Japanese Journal of Clinical Oncology, 28(8), 1998, pp. 502-506
SUCCESSFUL TREATMENT WITH NEDAPLATIN IN PATIENTS WITH OVARIAN-CANCER THAT RECURRED AFTER PLATINUM-CONTAINING CHEMOTHERAPY - REPORT OF 2 CASES
Authors: ITOH K YAMASHITA T WAKITA H WATANABE Y KODAMA K FUJII H MINAMI H OHTSU T IGARASHI T SASAKI Y
Citation: K. Itoh et al., SUCCESSFUL TREATMENT WITH NEDAPLATIN IN PATIENTS WITH OVARIAN-CANCER THAT RECURRED AFTER PLATINUM-CONTAINING CHEMOTHERAPY - REPORT OF 2 CASES, Japanese Journal of Clinical Oncology, 28(5), 1998, pp. 343-346
SUCCESSFUL TREATMENT BY RADIATION AND HORMONE-THERAPY OF ISOLATED LOCAL RECURRENCE OF BREAST-CANCER 24 YEARS AFTER MASTECTOMY ACCOMPANIED BY IMMUNE THROMBOCYTOPENIA - A CASE-REPORT
Authors: IGARASHI T ITOH K FUJII H OHTSU T MINAMI H SASAKI Y SHIMIZU W OGINO T MURAMATSU M
Citation: T. Igarashi et al., SUCCESSFUL TREATMENT BY RADIATION AND HORMONE-THERAPY OF ISOLATED LOCAL RECURRENCE OF BREAST-CANCER 24 YEARS AFTER MASTECTOMY ACCOMPANIED BY IMMUNE THROMBOCYTOPENIA - A CASE-REPORT, Japanese Journal of Clinical Oncology, 28(4), 1998, pp. 270-275
DETERMINATION OF CYTOSOL C-ERBB-2 PROTEIN IN BREAST-CANCER BY SANDWICH ENZYME-IMMUNOASSAY
Authors: IMOTO S OHKURA H SUGANO K SASAKI Y ITO K IGARASHI T OHTSU T FUJII H MINAMI H HASEBE T MUKAI K
Citation: S. Imoto et al., DETERMINATION OF CYTOSOL C-ERBB-2 PROTEIN IN BREAST-CANCER BY SANDWICH ENZYME-IMMUNOASSAY, Japanese Journal of Clinical Oncology, 28(2), 1998, pp. 92-96
PHARMACOKINETIC STUDY OF LOW-DOSE VERSUS HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) IN WOMEN
Authors: OHTSU T FUJII H WAKITA H IGARASHI T ITOH K IMOTO S KOHAGURA M SASAKI Y
Citation: T. Ohtsu et al., PHARMACOKINETIC STUDY OF LOW-DOSE VERSUS HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) IN WOMEN, Cancer chemotherapy and pharmacology, 42(1), 1998, pp. 1-8
ANTITUMOR-ACTIVITY OF DOXORUBICINOL IN COMBINATION WITH SDZ PSC833 TOWARDS DRUG-RESISTANT TUMOR-CELLS AND ITS TOXICITY TO HUMAN HEMATOPOIETIC PROGENITORS
Authors: IGARASHI T WATANABE T UCHIYAMA N NAKAJIMA M OHTSU T ITOH K FUJII H MINAMI H SASAKI Y
Citation: T. Igarashi et al., ANTITUMOR-ACTIVITY OF DOXORUBICINOL IN COMBINATION WITH SDZ PSC833 TOWARDS DRUG-RESISTANT TUMOR-CELLS AND ITS TOXICITY TO HUMAN HEMATOPOIETIC PROGENITORS, Experimental hematology, 26(8), 1998, pp. 390-390
SOLVOLYSIS OF 2-THIOXO BICYCLIC BRIDGEHEAD DERIVATIVES - EVALUATION OF PI-CONJUGATIVE STABILIZATION OF ALPHA-THIOCARBONYL CARBOCATIONS
Authors: TOKUNAGA K OHTSU T OHGA Y TAKEUCHI K
Citation: K. Tokunaga et al., SOLVOLYSIS OF 2-THIOXO BICYCLIC BRIDGEHEAD DERIVATIVES - EVALUATION OF PI-CONJUGATIVE STABILIZATION OF ALPHA-THIOCARBONYL CARBOCATIONS, Journal of organic chemistry, 63(7), 1998, pp. 2209-2217
HOW DROSOPHILA SPECIES ACQUIRE COLD TOLERANCE - QUALITATIVE CHANGES OF PHOSPHOLIPIDS
Authors: OHTSU T KIMURA MT KATAGIRI C
Citation: T. Ohtsu et al., HOW DROSOPHILA SPECIES ACQUIRE COLD TOLERANCE - QUALITATIVE CHANGES OF PHOSPHOLIPIDS, European journal of biochemistry, 252(3), 1998, pp. 608-611
INDIRECT-RESPONSE MODEL FOR THE TIME-COURSE OF LEUKOPENIA WITH ANTICANCER DRUGS
Authors: MINAMI H SASAKI Y SAIJO N OHTSU T FUJII H IGARASHI T ITOH K
Citation: H. Minami et al., INDIRECT-RESPONSE MODEL FOR THE TIME-COURSE OF LEUKOPENIA WITH ANTICANCER DRUGS, Clinical pharmacology and therapeutics, 64(5), 1998, pp. 511-521
NUCLEIC-ACID ANALOG PEPTIDE (NAAP) .2. SYNTHESES AND PROPERTIES OF NOVEL DNA ANALOG PEPTIDES CONTAINING NUCLEOBASE LINKED BETA-AMINOALANINE
Authors: FUJII M YOSHIDA K HIDAKA J OHTSU T
Citation: M. Fujii et al., NUCLEIC-ACID ANALOG PEPTIDE (NAAP) .2. SYNTHESES AND PROPERTIES OF NOVEL DNA ANALOG PEPTIDES CONTAINING NUCLEOBASE LINKED BETA-AMINOALANINE, Bioorganic & medicinal chemistry letters, 7(5), 1997, pp. 637-640
PHASE-I STUDY OF DEC-C2B8 [RITUXIMAB] IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL [CD20-HODGKINS-LYMPHOMA IN JAPAN(] NON)
Authors: OGURA M MORISHIMA Y KOBAYASHI Y SASAKI Y OHTSU T MURATE T KINOSHITA T TOBINAI K
Citation: M. Ogura et al., PHASE-I STUDY OF DEC-C2B8 [RITUXIMAB] IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL [CD20-HODGKINS-LYMPHOMA IN JAPAN(] NON), Experimental hematology, 25(8), 1997, pp. 407-407
NUCLEIC-ACID ANALOG PEPTIDE (NAAP) - SOLID-PHASE SYNTHESIS OF A DNA ANALOG PEPTIDE
Authors: FUJII M YAMAMOTO K HIDAKA J OHTSU T
Citation: M. Fujii et al., NUCLEIC-ACID ANALOG PEPTIDE (NAAP) - SOLID-PHASE SYNTHESIS OF A DNA ANALOG PEPTIDE, Tetrahedron letters, 38(3), 1997, pp. 417-420
CLINICOPATHOLOGICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF GASTRICLYMPHOMA
Authors: MATSUNOTO S OHTSU A BOKU N FUJII T TAJIRI H YOSHIDA S OHTSU T MUKAI K
Citation: S. Matsunoto et al., CLINICOPATHOLOGICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF GASTRICLYMPHOMA, Gut, 41, 1997, pp. 159-159
CLINICOPATHOLOGICAL CHARACTERISTICS OF GASTRIC LYMPHOMA IN JAPAN
Authors: MATSUMOTO S OHTSU A BOKU N FUJII T TAJIRI H YOSHIDA S OHTSU T MUKAI K
Citation: S. Matsumoto et al., CLINICOPATHOLOGICAL CHARACTERISTICS OF GASTRIC LYMPHOMA IN JAPAN, Gastroenterology, 112(4), 1997, pp. 611-611
PATIENTS IN PHASE-I TRIALS OF ANTI CANCER AGENTS IN JAPAN - MOTIVATION, COMPREHENSION AND EXPECTATIONS
Authors: ITOH K SASAKI Y FUJII H OHTSU T WAKITA H IGARASHI T ABE K
Citation: K. Itoh et al., PATIENTS IN PHASE-I TRIALS OF ANTI CANCER AGENTS IN JAPAN - MOTIVATION, COMPREHENSION AND EXPECTATIONS, British Journal of Cancer, 76(1), 1997, pp. 107-113
A CASE OF EXTRAGONADAL GERM-CELL TUMOR WITH ELEVATED POSTCHEMOTHERAPYHCG SUCCESSFULLY TREATED BY RESECTION OF A SOLITARY METASTASIS AND CHRONIC ORAL ETOPOSIDE
Authors: OHTSU T IGARASHI T WAKITA H ITOH K FUJII H YOSHIDA J HASEBE T SASAKI Y
Citation: T. Ohtsu et al., A CASE OF EXTRAGONADAL GERM-CELL TUMOR WITH ELEVATED POSTCHEMOTHERAPYHCG SUCCESSFULLY TREATED BY RESECTION OF A SOLITARY METASTASIS AND CHRONIC ORAL ETOPOSIDE, Japanese Journal of Clinical Oncology, 26(2), 1996, pp. 107-111
PROGRESS IN PRECLINICAL AND CLINICAL-STUDIES FOR THE DEVELOPMENT OF NEW ANTICANCER DRUGS IN JAPAN, WITH EMPHASIS ON TAXANES
Authors: SAIJO N NISHIO K OHTA S ARIOKA H FUNAYAMA Y FUKUOKA K KUROKAWA H NOMOTO T ISHIDA T YAMAMOTO N TAMURA T SHINKAI T EGUCHI K OHE Y KUNITO H OHTSU T SASAKI Y
Citation: N. Saijo et al., PROGRESS IN PRECLINICAL AND CLINICAL-STUDIES FOR THE DEVELOPMENT OF NEW ANTICANCER DRUGS IN JAPAN, WITH EMPHASIS ON TAXANES, Cancer chemotherapy and pharmacology, 38, 1996, pp. 11-15
RECURRENT BREAST-CANCER TREATED SUCCESSFULLY WITH MITOMYCIN-C AND VINBLASTINE AFTER FAILURE OF BOTH DOXORUBICIN-CONTAINING REGIMEN AND PACLITAXEL - A CASE-REPORT
Authors: SEKINE I SASAKI Y FUJII H OHTSU T WAKITA H IGARASHI T ITOH K ABE K
Citation: I. Sekine et al., RECURRENT BREAST-CANCER TREATED SUCCESSFULLY WITH MITOMYCIN-C AND VINBLASTINE AFTER FAILURE OF BOTH DOXORUBICIN-CONTAINING REGIMEN AND PACLITAXEL - A CASE-REPORT, Tohoku Journal of Experimental Medicine, 178(3), 1996, pp. 331-337
OFF-TRACK PERFORMANCE OF PSEUDO SIDE ERASING WRAPAROUND HEADS FOR DISK-DRIVE APPLICATION
Authors: OHTSU T KUSHIDA N KAWAKAMI K IWAKURA T KODAMA N NARISHIGE S
Citation: T. Ohtsu et al., OFF-TRACK PERFORMANCE OF PSEUDO SIDE ERASING WRAPAROUND HEADS FOR DISK-DRIVE APPLICATION, IEEE transactions on magnetics, 32(5), 1996, pp. 3491-3493
ANALYSIS OF THE RELATIONSHIP BETWEEN PK AND PD OF PACLITAXEL (P)
Authors: FUJII H OHTSU T SASAKI Y
Citation: H. Fujii et al., ANALYSIS OF THE RELATIONSHIP BETWEEN PK AND PD OF PACLITAXEL (P), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 47-47
Risultati: 1-25 | 26-37